/cloudfront-us-east-2.images.arcpublishing.com/reuters/QTMDGJIRG5K5XGUZFMKHNLOVOI.jpg?fit=%2C&ssl=1 "Pfizer to test COVID-19 vaccine in larger group of children below 12")
Family members look on as Jack Frilingos, 12, is inoculated with Pfizer’s vaccine against coronavirus disease (COVID-19) after Georgia authorized the vaccine for ages over 12 years, at Dekalb Pediatric Center in Decatur, Georgia, U.S. May 11, 2021. REUTERS/Chris Aluka Berry/File Photo
Pfizer Inc (PFE.N) said on Tuesday it will begin testing its COVID-19 vaccine in a bigger group of children under age 12 after selecting a lower dose of the shot in an earlier stage of the trial.
The study will enroll up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland…
